Abstract 64 Table 1 Important baseline characteristics of both groups showing no significant statistical difference

Baseline criteriaWeight adjusted dose groupFixed dose groupP value
Age (yr) 67, 55­77 68, 58–76 0.683
Male (%) 70 76 0.292
Body weight (kg) 79, 70–94 85, 75–96 0.088
Creatinine (Ã,µ mol/L) 79, 67–92 79, 68–94 0.506
Known diabetic (%) 28 24 0.312
Elective procedure (%) 41 43 0.765
Diagnostic catheterisation (%) 38 38 0.960
Coronary intervention (%) 62 62 0.960
Baseline ACT (seconds) 130, 121–143 131, 122–148 0.446